• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
H.C. Wainwright Analyst Reiterates Buy Rating on Ocugen
11:32
Nov5
Ocugen released FY2025 Q3 earnings on November 5 Pre-Market EST, actual revenue USD 1.752 M (forecast USD 440 K), actual EPS USD -0.0699 (forecast USD -0.056)
14:30
Ocugen released FY2025 9 Months Earnings on November 5, Pre-Market EST, with actual revenue of USD 4.606 M and EPS of USD -0.1689
14:30
Ocugen Inc. Reports Clinical Trial Progress and Completes $20 Million Direct Offering
11:30
Oct29
Ocugen to Release FY2025 Q3 Earnings on November 5, Pre-Market EST; Forecast Revenue USD 440 K, EPS USD -0.056
00:47
Oct2
Ocugen Executives to Attend Multiple Conferences to Share Progress in Blindness Gene Therapy
11:31

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.752 M, Net Income -20.05 M, EPS -0.0659

Aug1
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.373 M, Net Income -14.74 M, EPS -0.0504

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.481 M, Net Income -15.35 M, EPS -0.0525

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More